For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) In Vivo Pharmacokinetic (PK) Study Service
Are you currently facing long drug development cycles, challenges in obtaining reliable preclinical data, or difficulties in predicting clinical outcomes for your lead drug candidates? Our Non-Human Primate In Vivo PK Service helps you accelerate drug discovery and streamline clinical trial processes through the use of an integrated, end-to-end platform. We provide the essential data required to de-risk your program and ensure a seamless transition from preclinical research to human trials.
Introduction of Non-Human Primate In Vivo PK Studies
For a significant number of modern therapeutics, particularly biologics like monoclonal antibodies and gene therapies, non-human primates (NHPs) are the preferred—and often the only—preclinical species that accurately predicts human response. Their close genetic and physiological similarities to humans make them an indispensable model for evaluating a drug's absorption, distribution, metabolism, and excretion (ADME). These studies provide critical insights into a drug's behavior, safety, and efficacy.
What Our Service Is
NHP In Vivo PK Service provide a comprehensive evaluation of how a drug behaves within a living system. This service is crucial for translating in vitro findings into predictive data for clinical trials. Our services include:
-
Single and Multiple-Dose PK Profiling: These services measure the concentration of a drug in the body over time after a single or repeated administration.
- Determining the appropriate dosing regimen for first-in-human trials; evaluating drug accumulation or clearance kinetics over a long-term treatment period.
-
Tissue Distribution & Mass Balance: We track where a drug goes in the body and how it is eliminated.
- Identifying potential off-target toxicity by measuring drug concentrations in specific organs; understanding the primary pathways of drug excretion (e.g., renal vs. hepatic).
-
Food Effect & DDI (Drug-Drug Interaction): This service assess how food intake or co-administered drugs impact the pharmacokinetics of your candidate.
- Application Scenarios: Informing clinical trial protocol on whether a drug should be taken with or without food; predicting potential adverse interactions when your drug is co-prescribed with common medications.
-
PK/PD Modeling & Simulation: This involves building mathematical models to describe the relationship between drug exposure (PK) and its therapeutic or toxic effects (PD).
- Optimizing dosing strategies to achieve the desired therapeutic effect while minimizing side effects; predicting human PK/PD profiles based on preclinical data to enhance clinical trial design.
Why Choose Us?
The value we create for our clients is rooted in solving their most pressing pain points. The high cost and complexity of NHP service can create significant bottlenecks. We provide a streamlined, high-quality solution that transforms these challenges into clear benefits:
- Long, unpredictable study timelines: We offer a rapid turnaround time and clear communication, helping you keep your program on schedule.
- Difficulty in finding a reliable NHP partner: Our robust NHP resources and expertise ensure a consistent supply of healthy, well-characterized research models.
- Lack of clarity in study design and data interpretation: Our expert scientists work collaboratively with you to design a tailored protocol and provide in-depth analysis, ensuring you get actionable insights, not just raw data.
Fig.1 Serum concentrations of pro-inflammatory cytokines following HDAd5/35++ administration in Rhesus Macaques.1
Key Benefits of Our Service
Creative Biolabs' Non-Human Primate In Vivo PK Service stands apart due to our unwavering commitment to quality, efficiency, and flexibility. Our unique features are designed to give your project a decisive advantage.
- Rapid Response Speed: Our agile project management system ensures a swift project initiation and execution, minimizing delays in your drug development pipeline.
- Robust NHP Resources: We maintain access to a large population of readily available non-human primates, including Cynomolgus, Rhesus, Marmoset, and African Green Monkey, enabling us to support projects of all sizes with unparalleled consistency and reliability.
- Exceptional Customization: We understand that every project is unique. Our scientific team partners with you to design fully customized study protocols that precisely meet your research objectives, whether for small molecules, biologics, or complex new modalities.
- In-depth Reporting: Beyond the standard data tables, our comprehensive reports include detailed analysis, expert interpretations, and actionable insights to guide your next steps.
How Creative Biolabs' Service Can Assist Your Project?
Our service provides clear and compelling deliverables that solve critical problems in preclinical drug development. We help you de-risk your program by providing high-confidence data on a drug's behavior in vivo, enabling informed decision-making and a faster, more efficient path to the clinic. From confirming target engagement to predicting human dosing, our services are the bridge between discovery and clinical reality.
Required Starting Materials
Protocol Design & Review
Study Execution
Bioanalytical Analysis
Data Processing & PK Analysis
Final Reporting
Key Deliverables
The tangible outputs you receive from our service are designed to be comprehensive and immediately actionable.
- Final Study Report: A detailed, regulatory-compliant document summarizing the entire study.
- Raw Data Files: All raw data from sample analysis and PK calculations.
- PK/PD Analysis Report: A separate document providing expert interpretation and modeling of the data.
- Archived Samples: The option to have residual samples stored for future analysis.
Capabilities & Partnerships
Service-Specific Data
Our commitment to excellence is reflected in our robust capabilities and strategic partnerships.
- Annual Sample Size: Over 50,000 samples processed annually for NHP PK Service.
- Turnaround Time (TAT): Typical TAT of 2-4 weeks from sample collection to final data report.
- Pass Rate: Consistently >98% success rate for established methods.
Our Valued Partners
Frequently Asked Questions
Contact Us
Creative Biolabs is a leading partner in preclinical research, providing a comprehensive and reliable Non-Human Primate In Vivo PK service. From expert study design to in-depth data analysis, we are committed to accelerating your path to the clinic with high-quality, actionable data. Our integrated platform, robust NHP resources, and client-centric approach are all designed to ensure your project's success. To learn more about how our services can meet your needs, please contact us today.
Reference
- Li, Chang, et al. "Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors." Molecular Therapy Methods & Clinical Development 24 (2022). Distributed under Open Access license CC BY 4.0, without modification. DOI: https://doi.org/10.1016/j.omtm.2021.12.003